1344-48-5

Basic information

• Product Name: Mercury(II) sulfide
• Synonyms: Almaden;C.I. 77766;Ethiops mineral;Mercuric sulfide black;Mercuric sulfide;Mercuric sulfide red;Mercury monosulfide;Mercury sulfide;Mercury sulphide;Mercury(2+) sulfide;Monomercury sulfide;Orange vermilion;Pigment red 106;Red Cinnabar;Red mercury sulphide;Red mercuricsulfide;Scarlet vermilion;Vermilion;Vermilion (HgS);Vermillion;b-Mercuric sulfide
• CAS NO: 1344-48-5
• Molecular Formula: HgS
• Molecular Weight: 232.65
• EINECS: 215-696-3
• Mol File: 1344-48-5.mol

Chemical Properties

• Melting Point: 583.5 °C(lit.)
• Boiling Point: 584 °C
• Appearance: Odorless red or black solid
• Density: 8.1 g/mL at 25 °C
• CAS DataBase Reference: Mercury(II) sulfide(CAS DataBase Reference)
• NIST Chemistry Reference: Mercury(II) sulfide(1344-48-5)
• EPA Substance Registry System: Mercury(II) sulfide(1344-48-5)

Safety Data

• Hazard Codes: N-T:
• Statements: 50/53-36-33-23/24/25:
• Safety Statements: 61-60-45-36/37/39-28A-26:
• Hazardous Substances Data: 1344-48-5(Hazardous Substances Data)

Usage

InChI:InChI=1/Hg.S/q+2;-2

Relevant articles and documents

Tetrahydropteridines for treatment of neurological disorders

Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric and neurological disorders are disclosed.

Metal-containing steroid mimics and ligands useful in the preparation thereof

Metal-containing steroid mimic complexes are provided. Compositions containing a metal ion incorporated into a steroid skeleton structure and ligands useful in the preparation of such compositions are also provided. The metal ion is preferably a radionucl

Esters of mercapto acyl-carnitines and pharmaceutical compositions containing same

A novel class of esters of mercapto acyl-carnitines is disclosed, wherein the mercapto acyl radical is the radical of saturated mercapto acids having from 2 to 10 carbon atoms. These esters of mercapto acyl-carnitines are prepared e.g. by first preparing

Alcohol derivatives

This invention relates to alcohol derivatives which are histamine H-2 antagonists and which inhibit gastric acid secretion. According to the invention there is provided a guanidine derivative of the formula I: STR1 in which R1 and R2, same or different, are hydrogen or 1-10C alkyl, 3-8C cycloalkyl or 4-14C cycloalkylalkyl, each alkyl, cycloalkyl or cycloalkylalkyl optionally carrying one or more F, Cl or Br atoms, provided that one of R1 and R2 is halogen-substituted, or R2 is hydrogen and R1 is R5 --E--W-- in which W is 2-6C alkylene optionally substituted by 1 or 2 1-4C alkyl, E is O, S, SO, SO2 or NR6 in which R6 is H or 1-6C alkyl, R5 is H or 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls, or R5 and R6 are joined to form a pyrrolidine, piperidine, morpholine, piperazine or N-methylpiperazine ring, or R2 is hydrogen and R1 is hydrogen or 1-10C alkyl, 3-8C cycloalkyl, 4-14C cycloalkylalkyl, 3-6C alkenyl, 3-6C alkynyl, 1-6C alkanoyl, 6-10C aryl, 7-11C arylalkyl or 7-11C aroyl, the aryl, arylalkyl and aroyl radicals being optionally substituted, ring X is a heterocyclic ring as defined in the specification; A is phenylene or 5-7C cycloalkylene or a 1-8C alkylene into which is optionally inserted one or two groups; D is oxygen or sulphur; R3, R4 and R5 are hydrogen or a variety of radicals described in the specification: and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing processes and pharmaceutical compositions are also described.

Long-lasting agonists of enkephalin

Novel peptides of the formula: STR1 wherein X is S or (CH2)n and n is 0, 1 or 2, and R1 through R6 are various amino acid and other substituents; having long-lasting enkephalin agonist activity; useful in treati

1-Substituted-2-(substituted-imino)-1H-1,2-dihydrobenz[cd]indoles

Novel 1-substituted-2-(substitutedimino)-1H-1,2-dihydrobenz[cd]indoles useful as inhibitors of platelet aggregation.

2-(4-Methoxyoxazolidinone-4-yl)thiazolidine t-butyl esters

6-acylamido-6-methoxypenicillanic acids are obtained by reacting a 6-acylamidopenicillanic acid with mercuric acetate in methanol to yield a methyl α-methoxypenicilloate. Esterification of the latter with isobutylene affords the methyl, t-butyl diester of the methoxypenicilloic acid which undergoes selective hydrolysis in base to provide the free α-carboxylic acid half t-butyl ester of the penicilloic acid. The latter on reaction with dicyclohexylcarbodiimide affords an oxazolone-thiazolidine of the formula STR1 WHICH WITH 98% FORMIC ACID PROVIDES A COMPOUND OF THE INVENTION.

Certain 3-furyl sulfides

Novel 3-sulfur derivatives of furan including alkyl furan-3-thiols and bis(alkyl-3-furyl) sulfides and di- and tetrahydro derivatives thereof having meaty and/or roasted aromas and flavors; processes for producing such 3-sulfur derivatives; novel flavoring compositions containing such derivatives; and novel food compositions containing such derivatives.

3-(P-methoxybenzylthio)2-non-oxocarbonylic pyridines

3-Thiolpicolinic acid is prepared by reacting a 3-halopyridine, having a 2-substituent which is hydrolyzable to a carboxy group, with an alkali metal salt of p-methoxybenzyl mercaptan, hydrolyzing the 2-substituent to a carboxy group and then cleaving the